Pleural fluid analysis of lung cancer vs benign inflammatory disease patients.

Br J Cancer · 2010 · PMC2853096 · PMID 20216542

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

Results Pleural fluid markers Pleural fluid marker analysis revealed highly significant differences in the levels of seven of the analysed markers between benign and lung cancer patients ( Table 1 , Figure 1 ): the concentrations of all seven markers, MMP-9, MMP-3, CycD1, Ki67, ImAnOx, carbonyls and p27, were lower in cancer patients by 9–65%.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.